BAD Primary Antibody
|Formulation||Purified antibody in PBS with 0.05% sodium azide.|
|Immunogen||Purified recombinant fragment of human BAD (AA: FULL(1-168)) expressed in E. Coli.|
|Shipping Information||This product will ship in a box containing blue ice at a temperature of 4°C. Learn More|
|FCM (Flow Cytometry)||1/200 - 1/400|
|WB (Western Blot)||1/500 - 1/2000|
Contact us to order
Figure 1: Western blot analysis using BAD mAb against human BAD (AA: FULL(1-168)) recombinant protein. (Expected MW is 44.3 kDa)
Figure 2: Western blot analysis using BAD mAb against HEK293 (1) and BAD (AA: FULL(1-168))-hIgGFc transfected HEK293 (2) cell lysate.
Figure 3: Western blot analysis using BAD mouse mAb against MCF-7 (1), HEK293 (2) cell lysate.
Figure 4: Flow cytometric analysis of MCF-7 cells using BAD mouse mAb (green) and negative control (red).
Black line: Control Antigen (100 ng); Purple line: Antigen(10ng); Blue line: Antigen (50 ng); Red line: Antigen (100 ng);
The protein encoded by this gene is a member of the BCL-2 family. BCL-2 family members are known to be regulators of programmed cell death. This protein positively regulates cell apoptosis by forming heterodimers with BCL-xL and BCL-2, and reversing their death repressor activity. Proapoptotic activity of this protein is regulated through its phosphorylation. Protein kinases AKT and MAP kinase, as well as protein phosphatase calcineurin were found to be involved in the regulation of this protein. Alternative splicing of this gene results in two transcript variants which encode the same isoform.
|References (references)||1. Clin Cancer Res. 2011 Oct 1;17(19):6356-66.|
2. Mol Cancer Res. 2010 Aug;8(8):1116-25.